Endocrine - Level 2 Flashcards
Definition of T1DM?
o Absolute insulin deficiency causing persistent hyperglycaemia
o Most common is immune for 1A
o Some slower progression form occur later in life (LADA)
Pathology of T1DM?
o Islet cell antibodies lead to insulitis and destruction of B cells in Islet of Langerhans causing insulin deficiency
Epidemiology of T1DM?
- Peak age is puberty but can be any age
- Usually lean
- Associated with autoimmune diseases of thyroid, blood, etc
Aetiology of T1DM?
o HLA-DR3/4
o Family history of Type 1
Environmental triggers of T1DM?
o Autoantibodies appear early (Glutamic acid decarboxylase)
o Diet
o Coxsackie virus
Acute symptoms of T1DM?
- Young people with 2-6 week history of thirst, polyuria, weight loss
- Ketoacidosis
Subacute symptoms of T1DM?
- Over month/years (type 2 commonly)
- Thirst, polyuria, weight loss, fatigue, visual blurring, infections
Diagnosis of T1DM?
Symptoms of hyperglycaemia
Fasting PG (8-hours) of ≥7mmol/L or random PG ≥11.1mmol/L 1 abnormal reading if symptomatic, 2 if asymptomatic
One or more of:
Ketosis, rapid weight loss, age <50, BMI <25, family history of autoimmune disease
Management if T1DM diagnosed?
- If type 1 diagnosed – refer same-day to diabetes specialist team
Initial care of newly diagnosed T1DM?
- Offer structured education programme – DAFNE programmed 6-12 post-diagnosis
- Teach self-monitoring of blood glucose
- Lifestyle changes – stop smoking, strict diet (low fat, sugar, high carbs), regular exercise and low alcohol intake
- Yearly influenza and pneumococcal vaccine
- Inform DVLA/insurance if having insulin
Drug treatment in T1DM?
Insulin
Advice on self-monitoring in insulin management of T1DM?
Targets?
When to give real time glucose monitoring?
When is sensor pump therapy given?
At least 4 times a day, before meals and before bed
• Encourage 10x/day if – poor control, hypo frequency increases, period of illness, around sport
Targets
• FPG 5-7 on waking, PG 4-7 before meals, PG 5-9 at least 90 mins after eating
Real time glucose monitoring used when patient has:
• >1 severe hypoglycaemia, loss of awareness of hypoglycaemia, frequent (>2/week) hypoglycaemias affecting ADLs, fear of hypoglycaemia, hyperglycaemia persistently (HbA1c >75)
• Can have multiple daily injection insulin or CSC insulin pump
Sensor-pump therapy given when:
• Episodes of hypoglycaemia despite continuous SC monitoring
Insulin regimens in T1DM?
Offer Basal-bolus regimen 1st line
Continuous insulin SC infusion (pump)
2x day pre-mixed 70:30
Basal-bolus regimen in T1DM?
Basal-bolus regimen 1st line
Long-acting insulin detemir BD 1st line
o Alternative: OD insulin glargine or insulin detemir
Offer rapid-acting insulin analogues before meals (Humalog/Novorapid)
Can adjust for meals and infections better
Need to test sugars more, at school inject (psychological)
Continuous insulin SC infusion in T1DM?
Continuous insulin SC infusion (pump)
- Recommended (children >12 and adults) if multiple daily injections result in disabling hypoglycaemia (repeated and unpredictable hypos that results in persistent anxiety about recurrence and effecting ADLs) OR HbA1c >69mmol/mol on MDI therapy
- Gives basal infusion and bolus when eat
- Needle changed every 2-3 days
- Cannot use in sports, swimming, baths (if disconnected – DKA)
Pre-mixed insulin in T1DM?
2x day pre-mixed 70:30
• Consider BD human mixed insulin if MDI basal-bolus regimen not possible
• Not suitable for kids’ normal daily activity
• Difficult to control/change insulin dosages
Adjunctive treatments if insulin not achieving adequate glycaemic control in T1DM?
Sotagliflozin/Dapagliflozin with insulin
• If BMI >27, when insulin does not provide adequate glycaemic control
• On >0.5u/kg/day of insulin
• Stop if not a sustained improvement (>3mmol/mol) of HbA1c in 6 months
Sick day rules in T1DM?
Increases insulin need
Monitor blood glucose more regularly (up to 10x/day)
Consider ketone monitoring
Keep hydrated
Seek medical attention if unable to keep fluids down
Management of T1DM in hospital?
Aim for 5-8mmol/litre during surgery or acute illness
IV insulin if – unable to eat or predicted to miss more than 1 meal or acute situation (major surgery, high-dose steroids, inotropes, sepsis) or circulatory compromise
Use SC insulin (including rapid acting insulin before meals) if eating – enable self-administration if willing
Accessories needed in insulin therapy of T1DM?
Insulin injection device
Needles
Blood glucose meter, test strips and lancets
Urine ketones
Blood ketones meter, test strips and lancets
Sharps bin
Glucagon oral gel/injection
Other drug management given in T1DM?
- Statin
o Atorvastatin 20mg
If >40, diabetes for >10 years, established nephropathy, CVD risk factors (obesity, hypertension) - Antihypertensive (intervention if no risk >135/85, if albuminuria or 2 features of metabolic syndrome >130/80)
o ACEi
o Others: BB, low-dose thiazides, CCB
When to refer to nephrologist in T1DM?
- To nephrologist if eGFR <30
Follow ups in T1DM?
- Measure HbA1c every 3-6 months – target 48mmol/mol
- Annually
o HbA1c
o Height, weight, waist circumference, BMI
o Smoking status
o Assess erectile dysfunction (offer PDE-5i)
o Monitor for neuropathy
o Check injection sites
o Assess awareness of hypoglycaemia with Gold/Clarke score
How to screen for retinopathy in T1DM?
GP referral on diagnosis and annually
Emergency review by ophthalmologist if:
o Sudden loss of vision, rubeosis iridis, pre-retinal/vitreous haemorrhage, retinal detachment
Refer to ophthalmologist if:
o Maculopathy (exudates near fovea, macula)
o Pre-proliferative retinopathy (venous bleeding, reduplication, multiple round or blot haemorrhages)
How to screen for diabetic foot problems in T1DM?
Diabetic foot problems (foot checks annually, monthly-weekly if at risk)
• Assess neuropathy (10g monofilament), ischaemia, ulcers, callus, infection, deformity, ABPI
• If active diabetic foot problem – refer within 1 working day
How to screen for nephropathy in T1DM?
Nephropathy (EMU for ACR, eGFR check)
• Start ACEi if confirmed nephropathy and T1DM
Prognosis of T1DM?
- Without insulin replacement – would die within days/weeks
- With insulin – live normal life and complication risk reduced by adherence to effective treatment
- Life expectancy is reduced by 10 years on average
Complications of T1DM?
o Macrovascular
Atherosclerosis – stroke, MI, PVD
o Microvascular
Affects all small vessels – particularly in retina and nerve sheath
Classes of diabetic eye disease in T1DM?
Diabetic retinopathy
1. Background – capillary microaneurysms, dot & blot haemorrhages, hard exudates
2. Pre-proliferative – soft “cotton wool” spots
3. Proliferative – New blood vessels, vitreous/retinal haemorrhages
4. Maculopathy – Bleeds/exudates encroach on macula causing decreased visual acuity
Cataracts
Nephropathy complications in T1DM?
o Damages by glomerular disease – thickening of basement membrane and glomerulosclerosis – microalbuminuria and decreased eGFR
Neuropathy complications in T1DM?
o Symmetrical sensory polyneuropathy
o Acute painful neuropathy
o Mononeuritis
Diabetic foot complications in T1DM?
o Ulcers due to neuropathy and vascular disease
Skin complications in T1DM?
o Lipohypertrophy
o Necrobiosis Lipoiditica – red plaques on skin
o Vitiligo – white patches
o Granuloma annulare – flesh coloured rings over extensor surface of fingers
Other complications in T1DM?
- Infection – especially UTI and skin
- Gastroparesis
Definition of T2DM?
- Type 2 diabetes defined as persistent hyperglycaemia (RPG >11) caused by deficient insulin secretion and resistance to action of insulin
Pathology of T2DM?
o Partial insulin deficiency and insulin resistance
o Body unable to secrete enough insulin to meet demands, insulin less able to bind to receptors due to resistance
o Beta cell mass <50% - hyperglycaemia worsens disease and progression to impaired fasting glucose
Epidemiology of T2DM?
- 2-4x more common in Asians, Africans
- One of most common chronic diseases in UK, prevalence increasing
Risk factors of T2DM?
- Older age
- FHx
- Hx of gestational diabetes
- Ethnicity – Asian, African
- Obesity
- Diet - High GI index food
- Hypertension/hyperlipidaemia
- Low birth weight
- Alcohol excess
- Drugs (steroids, statins, thiazide diuretic)
Symptoms of T2DM?
- Subacute with complications – infections, etc
- Polydipsia, polyuria, weight loss and fatigue
- Can be asymptomatic
What risk assessment is used in T2DM?
- Tool from Diabetes UK – gender, age, ethnicity, FHx, waist circumference, BMI, BP
- Gives risk score – low, intermediate, high
When is risk assessment offered in T2DM?
- Offer to:
o >40
o 25 and over in South Asian and Afro-Caribbean origin
o Adults with CVD, hypertension, stroke, obesity, PCOS, Hx of GDM
What to do if risk assessment shows low or intermediate risk score in T2DM?
lifestyle and reassess in at least next 5 years
What to do if risk assessment shows high risk score in T2DM?
HbA1c testing
o If FPG<5.5 or HbA1c <42 – reassess after 3 years
o If FPG 5.5-6.9 or HbA1c 42-47 – offer lifestyle advice, intensive lifestyle-change programme and reassess at least 1x per year
o If FPG>7.0 or HbA1c >48 – carry out second HbA1c and if confirmed – treat according to guidelines, if <48 offer lifestyle-change programme
HbA1c test - definitions and when to diagnose T2DM?
- Pre-diabetes 42mmol/mol-47mmol/mol
o Lifestyle advice only - Diagnosed when ≥48mmol/mol (or fasting PG ≥7.0mmol/L):
o Asymptomatic – two abnormal readings
o Symptomatic – one abnormal reading
Initial management in T2DM?
- Structured group education programme – DESMOND programme
- Lifestyle modifications – stop smoking, lose weight, foot care, regular exercise, treat risk factors
o Low glycaemic index foods, low fatty foods, high fibre
o Over a week, at least 150 minutes of moderate intensity physical activity (such as brisk walking or cycling) in bouts of 10 minutes or more
o Sick day rules – see diabetic teams
Drug treatment in T2DM - aims?
o Aim for 48 - if managed by lifestyle or one drug not associated with hypoglycaemia
o Aim for 53 - if drug associated with hypoglycaemia
o If HbA1c ≥58 - reinforce lifestyle advice, intensify drug treatment
Drug treatment in T2DM - self-monitoring?
o Only offer if on insulin, evidence of hypoglycaemic episodes, OHA with risk of hypoglycaemia while driving or operating heavy machinery or pregnant
Drug treatment in T2DM - when metformin appropriate - 1st line?
SR Metformin, titrate dose over weeks - 500mg OD with breakfast for at least 1 week, then 500mg BD for at least 1 week, then 500mg TDS to maximum 2g/day
Monitor renal function
Before (do not start if eGFR <30), annually if normal renal function, biannually if renal impairment
Stop if eGFR<30, caution if <45
Drug treatment in T2DM - when metformin appropriate - 1st intensification?
• Metformin + DPP-4 inhibitor (gliptins)OR
• Metformin + Pioglitazone OR
o Do not use pioglitazone if HF, hepatic impairment, DKA, current or Hx of bladder cancer, uninvestigated macroscopic haematuria
• Metformin + Sullfonylurea
Drug treatment in T2DM - when metformin appropriate - 2nd intensification?
• Metformin + DPP-4 inhibitor + sulfonylurea OR
• Metformin + pioglitazone + sulfonylurea OR
• Starting insulin-based treatment OR
• Metformin + sulfonylurea + GLP-1 mimetic (liraglutide)
o If – BMI >35 and psychological or medical problem associated with obesity or BMI<35 where insulin would have significant occupational implications or weight loss would benefit
• Metformin + DPP-4 inhibitor + ertugliflozin
• Metformin + sulfonylurea/thiazolidinedione + empagflozin/canagliflozin
Drug treatment in T2DM - when metformin not appropriate - 1st line?
• DPP-4 inhibitor OR pioglitazone OR sulfonylurea
Drug treatment in T2DM - when metformin not appropriate - 1st intensification?
- DPP-4 inhibitor + pioglitazone OR
- DPP-4 inhibitor + sulfonylurea OR
- Pioglitazone + sulfonylurea
Drug treatment in T2DM - when metformin not appropriate - 2nd intensification?
• Consider insulin-based treatment
When insulin indicated in T2DM - what regimen is used?
Continue metformin
Regimens:
• Offer NPH (isophane) insulin OD/BD
• Consider both NPH and short-acting either separately or pre-mixed
• Consider insulin detemir/glargine as alternative to NPH
• If metformin not used – gliptin plus sulfonylurea/pioglitazone or together
Other drug management in T2DM?
- Statin
o If QRISK2 is ≥10% and <84 years, atorvastatin 20mg - Antihypertensive
o Aim for <140/90
o Lifestyle advice for 2 months
o ACEi OD (ACEi + diuretic/CCB for Afro-Caribbean)
Add CCB
Add thiazide like diuretic
Alpha-blocker, Beta-blocker or spironolactone
Follow up in T2DM?
- Every review
o Measure height, weight, waist circumference, BMI
o Smoking status
o Assess neuropathy - Every 6 months
o Measure HbA1c every 3-6 months until stable and then 6-monthly
o If BP stable on medication (1-2 months until stable)
- Yearly o Retinopathy o Diabetic foot problems (foot checks monthly-weekly if at risk) o Nephropathy (EMU for ACR, eGFR check) o CVD (lipids, BP)
Names of gliptins?
- DPP-4 inhibitor
- Sitagliptin, vildagliptin, saxagliptin, linagliptin
names of thiazolidinediones?
- Stimulates nuclear receptor PPAR-Gamma
- Can cause fluid retention, anaemia
- Pioglitazone, rosiglitazone
Names of flozins, SE?
- SGLT2 inhibitor
- Common SE UTIs, joints pains, fungal infection
Names of GLP-1 mimetics?
- Glucagon-like peptide 1 receptor agonists (GLP-1 receptor agonists)
- Liraglutide
- Used if insulin cannot be used or need weight loss
Prognosis of T2DM?
- Optimal management, usually patients live normal life but may have complications
- Reduced life expectancy by average of 10 years
How to assess diabetic foot infection in diabetes?
o Neuropathy (10g monofilament as part of sensory foot exam) o Limb ischaemia (pulses, CRT) o Ulcers o Callus o Infection o Deformity o Gangrene o Charcot arthropathy
Management of low risk diabetic foot disease?
annual foot assessments, emphasise foot care importance
Management of moderate-to-high risk diabetic foot disease?
Refer to foot protection services
Assess within 2-4 weeks (high) or 6-8 weeks (moderate)
Assessment in foot protection services?
- Assess feet
- Advice, skin and nail care
- Biomechanical status of feet, specialist footwear provision
- Vascular status
When to reassess diabetic foot problems?
- Annual – low risk
- 3-6 months – moderate risk
- 1-2 months – high risk (no immediate concern)
- 1-2 weeks – high risk (immediate concern)
When to refer diabetic foot problems to hospital?
Ulcer with fever or signs of sepsis
Ulcer with limb ischaemia
Deep-seated soft tissue or bone infection
Gangrene
Management of Charcot arthropathy?
o Suspect Charcot arthropathy if red, warm, swollen and deformed foot
Refer within 1 working day to MDT foot care service for triage
Definiton of Charcot’s arthropathy?
Deformed foot
Rocker bottom foot
Collapsed medial arch
Investigations of Charcot’s arthropathy?
Weight-bearing X-ray of foot and ankle
MRI if X-ray normal but still suspected
Management of Charcot’s arthropathy?
Non-removable/Removable offloading device
Monitor with foot-skin temperature difference and X-rays until resolves
Investigations in diabetic foot infections?
Soft tissue or bone sample from base of debrided wound for microbiology
FBC/ESR/CRP/blood cultures
X-ray of foot
MRI
Management in diabetic foot infections?
Antibiotics
• Mild – Oral flucloxacillin 500mg-1g QDS for 7 days (clarithromycin/doxycycline/erythromycin)
• Moderate/Severe
- IV flucloxacillin 1g QDS +/- Gentamicin +/- Metronidazole
- IV Co-amoxiclav +/- Gentamicin
- IV Co-trimoxazole +/- Gentamicin +/- Metronidazole
- IV Ceftriaxone +/- Metronidazole
• Pseudomonas aeruginosa
1. Tazocin 4.5g TDS IV
• MRSA
1. Vancomycin/Teicoplanin/Linezolid
o Review after 48 hours and consider oral switch
Investigations of diabetic foot ulcer?
Document size, depth and position of ulcer
Use SINBAD (Site, ischaemia, neuropathy, bacterial infection, area and depth) to classify
Management of diabetic foot ulcer?
Offloading (plantar, forefoot and midfoot)
Control infection/ischaemia
Wound debridement & dressing
• UrgoStart dressings
Description of Graves’ disease?
- Excess circulating thyroid hormones produced by overactive thyroid gland
Types of hyperthyroidism?
o Primary – causes by abnormal thyroid gland
Overt – TSH is low and T3/T4 high
Subclinical – TSH low and T3/T4 normal
o Secondary – abnormal stimulation of thyroid gland
Epidemiology of Graves’ disease?
- 10x more common in women
Risk factors of Graves’ disease?
o Women 10x o FHx of thyroid disease o Smoking o Low iodine intake o T1DM
Causes of primary hyperthyroidism?
Graves’ Disease
Toxic Multinodular Goitre
Toxic thyroid adenoma
Drugs
Definition of Grave’s disease?
- Most common cause, 75%
- Autoimmune disorder, antibodies that stimulate TSH leading to excessive secretion of thyroid hormones and hyperplasia of thyroid cells
- Causes toxic diffuse goitre
Definition of toxic multinodular goitre?
- Thyroid with >2 autonomously functioning thyroid nodules that secrete excess thyroid hormones (benign follicular adenomas)
- People >60, iodine deficient areas (Denmark)
Definition of toxic thyroid adenoma?
• Nodule produces enough hormone to supress TSH from pituitary and contralateral thyroid lobe
What drugs cause hyperthyroidism?
• Iodine (amiodarone, IV contrast), lithium, IFN-alpha
Causes of secondary hyperthyroidism?
High hCG (gestational, multiple pregnancy, choriocarcinoma, hydatidiform mole)
Pituitary adenoma